• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO MEDICAL CORPORATION CAPIOX FX OXYGENATOR; OXYGENATOR, CARDIOPULMONARY BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO MEDICAL CORPORATION CAPIOX FX OXYGENATOR; OXYGENATOR, CARDIOPULMONARY BYPASS Back to Search Results
Model Number N/A
Device Problem Increase in Pressure (1491)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 12/13/2023
Event Type  malfunction  
Manufacturer Narrative
A1: patient identifier: requested, not provided.A2: age & date of birth: requested, not provided.A3: patient sex: requested, not provided.A4: weight: requested, not provided.A5: ethnicity: requested, not provided.A6: race: requested, not provided.D4: udi: n/a as this product code is not exported to the us market.D6a: implanted date: device was not implanted.D6b: explanted date: device was not explanted.E3: occupation: clinical engineering.G4: pma/510(k): k130520.Investigation of the actual sample: visual inspection of the actual sample upon receipt no anomaly such as a breakage was found.The actual sample upon receipt was installed into a circuit consisting of tubes, and saline solution was circulated to measure the pressure drop.It was found that the pressure drop was high compared to the current product.The actual sample was filled with glutaraldehyde-containing saline solution and fixed, the housing and filter were removed, and visual inspection of the gas transfer part was performed.No anomaly was found in the condition of fiber winding.The fiber layer was removed gradually, and visual inspection of the gas transfer part was performed.Formation of blood clots was found.No anomaly was found in the condition of fiber winding.The outer cylinder was removed from the heat exchanger, and visual and magnifying inspections of the heat exchanger were performed.Formation of blood clots was found on the entire surface of the heat exchanger.Electron microscopic inspection of blood clots formed on the fiber and the heat exchanger was performed.Blood cell components such as red blood cells and deformed red blood cells (echinocytosis), as well as the formation of fibrin net, were found.Record review: the manufacturing record and the shipping inspection record of the actual sample no anomaly was found.Past complaint file no other similar report of the product with the involved product code/lot number was found.Cause of occurrence/conclusion: based on the investigation result, it was confirmed that the pressure drop of the actual sample upon receipt was high compared to the current product.In addition, formation of blood clots was found both on the fiber and the heat exchanger of the actual sample.However, the causal relationship between the formed blood clots and this event could not be clarified, and it was not possible to clarify the cause of occurrence.Relevant instructions for use (ifu) reference: "do not reduce heparin during circulation.Otherwise, blood clotting might occur." "adequate heparinization of the blood is required to prevent it from clotting in the system." terumo medical products (tmp) (importer) registration no.2243441 is submitting this report on behalf of ashitaka factory of terumo corporation (manufacturer) registration no.9681834.
 
Event Description
The user facility reported that an emergency coronary artery bypass graft (cabg) was performed for a patient in whom impella was introduced.Immediately after turning on the pump, the pre oxygenator pressure became 500 mmhg and the post oxygenator pressure became 400 mmhg, so the circuit was replaced.The circuit was replaced.The operation was completed without any problems.There was no harm to the patient.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CAPIOX FX OXYGENATOR
Type of Device
OXYGENATOR, CARDIOPULMONARY BYPASS
Manufacturer (Section D)
TERUMO MEDICAL CORPORATION
950 elkton blvd.
elkton MD 21921
Manufacturer (Section G)
TERUMO CORPORATION, ASHITAKA
reg. no. 9681834
150 maimaigi-cho
fujinomiya city, 418
JA   418
Manufacturer Contact
gina digioia
265 davidson ave
suite 320
somerset, NJ 08873
4103927218
MDR Report Key18461397
MDR Text Key332733009
Report Number9681834-2023-00272
Device Sequence Number1
Product Code DTZ
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K071494
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 01/07/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/07/2024
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Model NumberN/A
Device Catalogue NumberCX-XRY05015A
Device Lot Number230929
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/14/2023
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/13/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured09/29/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-